-
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON FRIDAY, JUNE 20, 20252025-06-20
-
VOLUNTARY ANNOUNCEMENT - AUMOLERTINIB MESILATE TABLETS WAS APPROVED BY THE MHRA FOR MARKETING2025-06-04
-
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 20252025-06-03
-
INSIDE INFORMATION - LICENSE AGREEMENT WITH REGENERON2025-06-02
-
VOLUNTARY ANNOUNCEMENT - THE THIRD BIOLOGICS LICENSE APPLICATION OF XINYUE (INEBILIZUMAB INJECTION) WAS ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION2025-05-30
-
NOTIFICATION LETTER TO NON-REGISTERED HOLDERS AND REQUEST FORM2025-05-29
-
NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM2025-05-29
-
FORM OF PROXY FOR THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, JUNE 20, 20252025-05-29
-
NOTICE OF ANNUAL GENERAL MEETING2025-05-29
-
(1) PROPOSED RE-ELECTION OF DIRECTORS, (2) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE SHARES, (3) PROPOSED DECLARATION OF FINAL DIVIDEND, (4) PROPOSED RE-APPOINTMENT OF AUDITORS AND (5) NOTICE OF ANNUAL GENERAL MEETING2025-05-29
-
VOLUNTARY ANNOUNCEMENT - THE CLINICAL TRIAL APPROVAL FOR HS-10510 TABLETS ISSUED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION2025-05-29
-
VOLUNTARY ANNOUNCEMENT - THE CLINICAL TRIAL APPROVAL FOR HS-10542 CAPSULES ISSUED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION2025-05-29
